Astrazeneca Pharma India Q2 Results
- BSE: 506820
- NSE: ASTRAZEN
- ISIN: INE203A01020
- Sector: Major Drugs
BSE
6,455.4
118.50 (1.87%)
118.50 (1.87%)Volume1.48 K
Updated: Mon 25 Nov, 2024 | 15:58:52
NSE
6,457.15137.30 (2.17%)
137.30 (2.17%)Volume14.74 K
Updated: Mon 25 Nov, 2024 | 15:44:21
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹408.00 Cr.(5.28%)
- Operating Profit₹43.20 Cr.(NA%)
- Profit After Tax₹38.43 Cr.(NA%)
- Operating Margin10.59%(-49.72%)
Note: Comparison is on YoY basis
Quarterly - Astrazeneca Pharma India Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 408.00 | 295.47 | -% | 311.07 | -% |
| Selling/ General/ Admin Expenses Total | 92.57 | 76.02 | -% | 82.02 | -% |
| Depreciation/ Amortization | 9.32 | 3.80 | -% | 3.67 | -% |
| Other Operating Expenses Total | 36.98 | 41.62 | -% | 54.16 | -% |
| Total Operating Expense | 364.80 | 232.02 | -% | 245.56 | -% |
| Operating Income | 43.20 | 63.45 | -% | 65.51 | -% |
| Net Income Before Taxes | 51.03 | 71.40 | -% | 73.38 | -% |
| Net Income | 38.43 | 53.86 | -% | 52.37 | -% |
| Diluted Normalized EPS | 15.37 | 21.54 | -% | 16.26 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST